CCL17 and CCL22 within tumors are known to be associated with an increased population of Foxp3+ Tregs; thus, the high expression of these 2 chemokines may contribute to the infiltration of Tregs into patients with Aden, thereby making the tumor microenvironment more immune suppressive. This evidence concerns the gene CCL22 and neoplasm.